Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Clinical trial NCT00738881 · TERMINATED

Trial details

NCT number: NCT00738881
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer

Start date: 2008-10-01
Primary completion: 2011-12-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.